KR, K., F, K., A, P., I, I., D, H., & H, K. (2022). Paralog- and ortholog-specificity of inhibitors of human and mouse lipoxygenase-isoforms. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 145, 112434. https://doi.org/10.1016/j.biopha.2021.112434
Chicago Style (17th ed.) CitationKR, Kakularam, Karst F, Polamarasetty A, Ivanov I, Heydeck D, and Kuhn H. "Paralog- and Ortholog-specificity of Inhibitors of Human and Mouse Lipoxygenase-isoforms." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 145 (2022): 112434. https://doi.org/10.1016/j.biopha.2021.112434.
MLA (9th ed.) CitationKR, Kakularam, et al. "Paralog- and Ortholog-specificity of Inhibitors of Human and Mouse Lipoxygenase-isoforms." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, vol. 145, 2022, p. 112434, https://doi.org/10.1016/j.biopha.2021.112434.